Sean Grant, Chief Financial Officer at Vera Therapeutics, Inc. (VERA), bought 5,000 shares at $13.60 ($68K) on 2022-06-15, disclosed to the SEC on 2022-06-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.60 | 335 | $5K | 6.7% |
| 2 | $13.60 | 857 | $12K | 17.1% |
| 3 | $13.60 | 992 | $13K | 19.8% |
| 4 | $13.60 | 2,816 | $38K | 56.3% |
| Total | $13.60 avg | 5,000 | $68K | 100% |
| Filing → |
| VERA | BUY | 2023-06-23 | $83K | — | Filing → |
| VERA | BUY | 2023-02-17 | $100K | — | Filing → |
| VERA | BUY | 2023-02-08 | $100K | — | Filing → |